Company intelligence / Profile preview

HekaBio

Ownership: Private
Employees: ~11
Development stage: Phase 1

Overview

HekaBio focuses on accelerating access to medicines and MedTech, particularly in Japan and Asia Pacific. It partners with companies like Limaca Medical to distribute innovative medical devices.

Therapeutic areas: Oncology
Modalities: Diagnostic and Therapeutic Innovations
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Alpha DaRT

Phase 1

Indications: Head and neck cancer, Skin cancer, Solid tumors

Partnerships

Limaca Medical

Beyond the preview

Go deeper on HekaBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HekaBio.

Explore the full profile